SRSF12 is a prognostic biomarker involved in immune infiltration in acute myeloid leukemia
Overall, our findings suggest that the high expression of SRSF12 in AML patients is a poor prognostic factor, which may provide a new option for the diagnosis, and targeted therapy of AML.
Authors
- Yehui Tan (ORCID: https://orcid.org/0000-0002-6378-2156)
- Meng Wang (ORCID: https://orcid.org/0000-0002-1573-0255)
- Mengmeng Zhang (ORCID: https://orcid.org/0000-0001-7632-7702)
- Zhibin Xie (ORCID: https://orcid.org/0009-0004-5981-687X)
- Jiajia Li (ORCID: https://orcid.org/0000-0003-0330-4264)
Institutions
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- Hematology
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1080/16078454.2024.2420301
- Citations
- 2
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.91